Medical Dialogues2d
Addition of Metformin to SGLT2 Inhibitors Lowers Kidney Disease Risk in Diabetes Patients: Study
Researchers have found in a new study that patients receiving a combination of metformin and SGLT2 inhibitors experienced a ...
Medscape2d
Major Changes Highlighted in New CKD Management Guidelines
Use of cystatin C for chronic kidney disease evaluation and sodium–glucose cotransporter-2 inhibitors as first-line therapy ...
Daily Maverick on MSN3d
New chronic kidney disease treatments show promise, but are expensive and inaccessible
While the exact number of people with chronic kidney disease in South Africa is unclear, estimates suggest it could be as ...
Medical Dialogues4d
Updated chronic kidney disease management guidelines recommend SGLT2 inhibitors regardless of diabetes or kidney disease type
Improving Global Outcomes (KDIGO) organization updated its existing clinical practice guideline in 2024 on evaluation and ...
MedPage Today on MSN6d
Updated CKD Guidelines Promote Cystatin C, Risk Equations, and SGLT2 Inhibitors
Use of cystatin C and SGLT2 inhibitors were highlighted in the Kidney Disease: Improving Global Outcomes (KDIGO) organization ...
Renal & Urology News3d
SGLT2 Inhibitors May Lower Stone Risk in Patients Regardless of Stone History
Compared with vs DPP4 inhibitors, SGLT2 inhibitors reduce the risk for kidney and ureteral stones in patients with type 2 diabetes, including those with a stone history. Sodium-glucose cotransporter 2 ...
Endocrinology Advisor4d
SGLT2 Inhibitors Might Lower Stone Risk Better Than Other Type 2 Diabetes Drugs
SGLT2 inhibitors may help reduce the risk of nephrolithiasis in patients with type 2 diabetes, including those with co-existing gout. Recent large-scale studies support that sodium-glucose ...
With drug Empagliflozin going off patent, doctors look forward to price reduction, benefitting diabetic, heart and kidney patients
Empagliflozin patent expiration in India leads to affordable treatment for diabetes, heart failure, and kidney disease.
The Cardiology Advisor12d
SGLT2 Inhibitor Use May Help Prevent Kidney Stones in Patients Without Diabetes
“Our data suggest SGLT2 inhibition as a safe strategy to prevent kidney stone recurrence in patients with kidney stones ,” Dr Fuster’s team concluded. Other study findings indicate the empagliflozin ...